ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
The Role of Reactive Oxygen Species in Ischaemia-Reperfusion Injury of the Transplanted Kidney

This study is ongoing, but not recruiting participants.

Sponsored by: Uniwersytet Mikolaja Kopernika w Toruniu
Information provided by: Uniwersytet Mikolaja Kopernika w Toruniu
ClinicalTrials.gov Identifier: NCT00204178
  Purpose

Measurement of reactive oxygen species production and antioxidant system status before and directly after reperfusion of the transplanted kidney and influence of oxidant stress on kidney function in 2 and 6 weeks.


Condition Intervention
Kidney Transplantation
Behavioral: Oxidative stress in kidney transplant recipients

MedlinePlus related topics:   Kidney Transplantation    Stress   

U.S. FDA Resources

Study Type:   Observational
Study Design:   Natural History, Cross-Sectional, Defined Population, Prospective Study
Official Title:   The Role of Reactive Oxygen Species in Ischaemia-Reperfusion Injury of the Transplanted Kidney

Further study details as provided by Uniwersytet Mikolaja Kopernika w Toruniu:

Estimated Enrollment:   60
Study Start Date:   April 2003
Estimated Study Completion Date:   September 2005

Detailed Description:

Oxidative stress is one of the most important factors in ischaemia-reperfusion injury to the transplanted organ. In kidney transplant recipients following factors were measured: glutathione level, activities of glutathione peroxidase (GSH-PX), catalase (CAT) and superoxide dismutase (SOD) and superoxide anion production by granulocytes in whole blood without and after the stimulation with zymosan.

Blood was sampled from peripheral vein (before reperfusion) and directly from renal vein (5 and 15 minutes after reperfusion).

Transplanted kidney function was evaluated by the incidence and length of Delayed Graft Function and serum creatinine level in 2 and 6 weeks after transplantation.

  Eligibility
Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Criteria

Inclusion Criteria:

  • consecutive patients accepted for and undergoing cadaveric kidney transplantation

Exclusion Criteria:

  • no informed consent
  Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00204178

Locations
Poland
Klinika Transplantologii, Szpital Uniwersytecki, ul. M. Sklodowskiej-Curie 9    
      Bydgoszcz, Poland, 85-094

Sponsors and Collaborators
Uniwersytet Mikolaja Kopernika w Toruniu

Investigators
Study Director:     Zbigniew Wlodarczyk, MD,PhD     Klinika Transplantologii Collegium Medicum UMK w Toruniu    
  More Information


Study ID Numbers:   KB/38/2003
First Received:   September 13, 2005
Last Updated:   November 30, 2005
ClinicalTrials.gov Identifier:   NCT00204178
Health Authority:   Poland: Ministry of Health

Keywords provided by Uniwersytet Mikolaja Kopernika w Toruniu:
Kidney transplantation  
Reperfusion injury  

Study placed in the following topic categories:
Postoperative Complications
Vascular Diseases
Ischemia
Reperfusion Injury

Additional relevant MeSH terms:
Pathologic Processes
Cardiovascular Diseases

ClinicalTrials.gov processed this record on October 16, 2008




Links to all studies - primarily for crawlers